Stay updated on Atrasentan in IgA Nephropathy Clinical Trial
Sign up to get notified when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.

Latest updates to the Atrasentan in IgA Nephropathy Clinical Trial page
- Check2 days agoChange DetectedThe page’s UI/version label has been updated from “Revision: v3.5.2” to “Revision: v3.5.3” without any accompanying change to the study content.SummaryDifference0.0%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision: v3.5.0 added; Revision: v3.4.3 removed.SummaryDifference0.0%

- Check52 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible changes to the study details or layout are observed.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision 3.4.1 replaces 3.4.0, indicating a minor maintenance update with no substantive changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Atrasentan in IgA Nephropathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atrasentan in IgA Nephropathy Clinical Trial page.